You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
ANI Pharmaceuticals, Inc.FDAMed source confidence · 80%Jun 22, 2026, 10:00 AM UTC · 16d ago
ANI Pharmaceuticals, Inc. — FDA Class II (D-0543-2026)
Case File
ANI Pharmaceuticals, Inc. is recalling 3,964 cartons of a human prescription drug due to defective containers. This recall is classified as a safety issue. The affected products have NDC numbers ranging from 70954-530 to 70954-534.
•ANI Pharmaceuticals is recalling 3,964 cartons of a human prescription drug.
•The recall is due to defective containers.
•Affected NDC numbers range from 70954-530 to 70954-534.
•Consumers should check their medicine cabinets for these products.
Why This Matters
Patients using these drugs should check for the recalled cartons, as they may be compromised. The recall affects 3,964 cartons of human prescription drugs.